U.S. Inhalation Anesthesia Market (2025 - 2030) Size, Share & Trends Analysis Report By Drug (Sevoflurane, Desflurane), By Application (Induction, Maintenance), By End Use (Hospitals, ASC), And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Drug
                        1.2.2. Application
                        1.2.3. End Use
                    1.3. Estimates and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                    1.6. Information Analysis
                        1.6.1. Data Analysis Models
                    1.7. Market Formulation & Data Visualization
                    1.8. Model Details
                        1.8.1. Commodity Flow Analysis
                    1.9. List of Secondary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Inhalation Anesthesia Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. Business Environment Analysis
                        3.3.1. Industry Analysis - Porter’s Five Forces Analysis
                            3.3.1.1. Supplier Power
                            3.3.1.2. Buyer Power
                            3.3.1.3. Substitution Threat
                            3.3.1.4. Threat of New Entrants
                            3.3.1.5. Competitive Rivalry
                        3.3.2. PESTLE Analysis
Chapter 4. U.S. Inhalation Anesthesia Market: Service Business Analysis
                    4.1. Drug Market Share, 2024 & 2030
                    4.2. Drug Segment Dashboard
                    4.3. Market Size & Forecasts and Trend Analysis, by Drug, 2018 to 2030 (USD Million)
                    4.4. Sevoflurane
                        4.4.1. Sevoflurane Market, 2018 - 2030 (USD Million)
                    4.5. Desflurane
                        4.5.1. Desflurane Market, 2018 - 2030 (USD Million)
                    4.6. Isoflurane
                        4.6.1. Isoflurane Market, 2018 - 2030 (USD Million)
                    4.7. Others
                        4.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. U.S. Inhalation Anesthesia Market: Formulation Business Analysis
                    5.1. Application Market Share, 2024 & 2030
                    5.2. Application Segment Dashboard
                    5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
                    5.4. Induction
                        5.4.1. Inhalation Anesthesia Market, for Induction, 2018 - 2030 (USD Million)
                    5.5. Maintenance
                        5.5.1. Inhalation Anesthesia Market, for Maintenance, 2018 - 2030 (USD Million)
Chapter 6. U.S. Inhalation Anesthesia Market: End Use Business Analysis
                    6.1. End Use Market Share, 2024 & 2030
                    6.2. End Use Segment Dashboard
                    6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
                    6.4. Hospitals
                        6.4.1. Inhalation Anesthesia Market, in Hospitals, 2018 - 2030 (USD Million)
                    6.5. Ambulatory Surgical Centers (ASC)
                        6.5.1. Inhalation Anesthesia Market, in Ambulatory Surgical Centers, 2018 - 2030 (USD Million)
                    6.6. Others
                        6.6.1. Inhalation Anesthesia Market, in Others, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Participant Overview
                    7.2. Company Market Position Analysis
                    7.3. Company Categorization
                    7.4. Strategy Mapping
                    7.5. Company Profiles/Listing
                        7.5.1. Baxter
                            7.5.1.1. Overview
                            7.5.1.2. Financial Performance
                            7.5.1.3. Product Benchmarking
                            7.5.1.4. Strategic Initiatives
                        7.5.2. AbbVie Inc.
                            7.5.2.1. Overview
                            7.5.2.2. Financial Performance
                            7.5.2.3. Product Benchmarking
                            7.5.2.4. Strategic Initiatives
                        7.5.3. Piramal Enterprises Ltd.
                            7.5.3.1. Overview
                            7.5.3.2. Financial Performance
                            7.5.3.3. Product Benchmarking
                            7.5.3.4. Strategic Initiatives
                        7.5.4. Hikma Pharmaceuticals PLC
                            7.5.4.1. Overview
                            7.5.4.2. Financial Performance
                            7.5.4.3. Product Benchmarking
                            7.5.4.4. Strategic Initiatives
                        7.5.5. Halocarbon, LLC
                            7.5.5.1. Overview
                            7.5.5.2. Financial Performance
                            7.5.5.3. Product Benchmarking
                            7.5.5.4. Strategic Initiatives
                        7.5.6. Sandoz Group AG
                            7.5.6.1. Overview
                            7.5.6.2. Financial Performance
                            7.5.6.3. Product Benchmarking
                            7.5.6.4. Strategic Initiatives
                        7.5.7. Fresenius Kabi AG
                            7.5.7.1. Overview
                            7.5.7.2. Financial Performance
                            7.5.7.3. Product Benchmarking
                            7.5.7.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. inhalation anesthesia market, by drug, 2018 - 2030 (USD Million)
Table 4 U.S. inhalation anesthesia market, by application, 2018 - 2030 (USD Million)
Table 5 U.S. inhalation anesthesia market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 U.S. inhalation anesthesia market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Drug outlook (USD Million)
Fig. 9 Application outlook (USD Million)
Fig. 10 End use outlook (USD Million)
Fig. 11 Competitive landscape
Fig. 12 U.S. inhalation anesthesia market dynamics
Fig. 13 U.S. inhalation anesthesia market: Porter’s five forces analysis
Fig. 14 U.S. inhalation anesthesia market: Pestle analysis
Fig. 15 U.S. inhalation anesthesia market: Drug segment dashboard
Fig. 16 U.S. inhalation anesthesia market: Drug market share analysis, 2024 & 2030
Fig. 17 Sevoflurane market, 2018 - 2030 (USD Million)
Fig. 18 Desflurane market, 2018 - 2030 (USD Million)
Fig. 19 Isoflurane market, 2018 - 2030 (USD Million)
Fig. 20 Other drug market, 2018 - 2030 (USD Million)
Fig. 21 U.S. inhalation anesthesia market: Application segment dashboard
Fig. 22 U.S. inhalation anesthesia market: Application market share analysis, 2024 & 2030
Fig. 23 Induction U.S. inhalation anesthesia market, for induction, 2018 - 2030 (USD Million)
Fig. 24 Induction U.S. inhalation anesthesia market, for maintenance, 2018 - 2030 (USD Million)
Fig. 25 U.S. inhalation anesthesia market: End use segment dashboard
Fig. 26 U.S. inhalation anesthesia market: End use market share analysis, 2024 & 2030
Fig. 27 Induction U.S. inhalation anesthesia market, in Hospitals, 2018 - 2030 (USD Million)
Fig. 28 Induction U.S. inhalation anesthesia market, in Ambulatory Surgical Centers, 2018 - 2030 (USD Million)
Fig. 29 Induction U.S. inhalation anesthesia market, in Others, 2018 - 2030 (USD Million)
Fig. 30 Company categorization
Fig. 31 Company market position analysis
Fig. 32 Strategic framework